Characterization of PARP1 in hepatocellular carcinoma, and evaluation of the potential of PARP1 inhibitor olaparib in HCC treatment

2018 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []